Pediatrix Reports Q3 2026 Net Revenue of $501.4 Million
Pediatrix Medical Group reported net income of $47.0 million, or $0.59 per diluted share. Adjusted diluted EPS was $0.72, versus $0.67 a year earlier. It forecast 2026 Adjusted EBITDA of $290 million to $300 million.